Role of circulating free DNA in evaluating clinical tumor burden and predicting survival in Chinese metastatic colorectal cancer patients.

MLA

Xu, Xiaojing, et al. “Role of Circulating Free DNA in Evaluating Clinical Tumor Burden and Predicting Survival in Chinese Metastatic Colorectal Cancer Patients.” BMC Cancer, vol. 20, no. 1, Oct. 2020, p. 1006. EBSCOhost, https://doi.org/10.1186/s12885-020-07516-7.

APA

Xu, X., Yu, Y., Shen, M., Liu, M., Wu, S., Liang, L., Huang, F., Zhang, C., Guo, W., & Liu, T. (2020). Role of circulating free DNA in evaluating clinical tumor burden and predicting survival in Chinese metastatic colorectal cancer patients. BMC Cancer, 20(1), 1006. https://doi.org/10.1186/s12885-020-07516-7

Chicago

Xu, Xiaojing, Yiyi Yu, Minna Shen, Mengling Liu, Shengchao Wu, Li Liang, Fei Huang, Chenlu Zhang, Wei Guo, and Tianshu Liu. 2020. “Role of Circulating Free DNA in Evaluating Clinical Tumor Burden and Predicting Survival in Chinese Metastatic Colorectal Cancer Patients.” BMC Cancer 20 (1): 1006. doi:10.1186/s12885-020-07516-7.